Janone Inc. (NASDAQ:ALTS) Sees Large Decline in Short Interest

Janone Inc. (NASDAQ:ALTS) saw a significant decline in short interest during the month of March. As of March 15th, there was short interest totalling 278,700 shares, a decline of 15.8% from the February 28th total of 331,000 shares. Currently, 2.0% of the shares of the company are sold short. Based on an average daily trading volume, of 221,200 shares, the short-interest ratio is presently 1.3 days.

Janone Stock Performance

Janone stock opened at $4.45 on Wednesday. The company’s 50-day moving average price is $5.43 and its two-hundred day moving average price is $3.95. The company has a debt-to-equity ratio of 1.96, a current ratio of 0.75 and a quick ratio of 0.75. Janone has a 52 week low of $1.29 and a 52 week high of $7.75.

About Janone

ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments.